Coffee Extracts Suppress Tryptophan Breakdown in Mitogen-Stimulated Peripheral Blood Mononuclear Cells

Journal of the American College of Nutrition

Volumn 34, Issue 3, 2015, Pages 212-223

  Gostner, Johanna M ^a   Schroecksnadel, Sebastian ^a   Jenny, Marcel ^a   Klein, Angela ^a   Ueberall, Florian ^a   Schennach, Harald ^b   Fuchs, Dietmar ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

3 dioxygenase; coffee; indoleamine 2; neopterin; peripheral blood mononuclear cells; tryptophan

Indexed keywords

BIOLOGICAL MARKER; CAFFEIC ACID; CAFFEINE; COFFEE EXTRACT; GALLIC ACID; GAMMA INTERFERON; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; NEOPTERIN; PHYTOHEMAGGLUTININ; PLANT EXTRACT; SEROTONIN; TRYPTOPHAN; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CAFFEIC ACID DERIVATIVE; CHLOROGENIC ACID; IMMUNOLOGIC FACTOR; IMMUNOSUPPRESSIVE AGENT; MITOGENIC AGENT;

ARTICLE; BIOCHEMISTRY; CELL ACTIVATION; CELL VIABILITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; ORAC ASSAY; PERIPHERAL BLOOD MONONUCLEAR CELL; TRYPTOPHAN METABOLISM; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; COFFEA; DRUG EFFECTS; METABOLISM; MONONUCLEAR CELL;

ANTI-INFLAMMATORY AGENTS; CAFFEIC ACIDS; CELLS, CULTURED; CHLOROGENIC ACID; COFFEA; GALLIC ACID; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MITOGENS; NEOPTERIN; PHYTOHEMAGGLUTININS; PLANT EXTRACTS; SEROTONIN; TRYPTOPHAN;

EID: 84929607337     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2014.907756     Document Type: Article

References (69)

1. J.V.Higdon, B.Frei: Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46:101–123, 2006.
2. Food Standards Agency: Food survey information sheet. Survey of caffeine levels in hot beverages. 2004. Accessed at: http://www.food.gov.uk/science/surveillance
3. J.Blanchard, S.J.Sawers: The absolute bioavailability of caffeine in man. Eur J Clin Pharmacol 24:93–98, 1983.
4. G.B.Kaplan, D.J.Greenblatt, B.L.Ehrenberg, J.E.Goddard, M.M.Cotreau, J.S.Harmatz, R.I.Shader: Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 37:693–703, 1997.
5. S.N.Alvi, M.M.Hammami: Validated HPLC method for determination of caffeine level in human plasma using synthetic plasma: application to bioavailability studies. J Chromatogr Sci 49:292–296, 2011.
6. D.A.Judelson, A.G.Preston, D.L.Miller, C.X.Muñoz, M.D.Kellogg, H.R.Lieberman: Effects of theobromine and caffeine on mood and vigilance. J Clin Psychopharmacol 33:499–506, 2013.
7. G.Thelander, A.K.Jönsson, M.Personne, G.S.Forsberg, K.M.Lundqvist, J.Ahlner: Caffeine fatalities—do sales restrictions prevent intentional intoxications? Clin Toxicol (Phila) 48:354–358, 2010.
8. Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A: Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care 16:R136, 2012.
9. B.Borrell: Plant biotechnology: make it a decaf. Nature 483:264–266, 2012.
10. M.N.Clifford: Chlorogenic acids and other cinnamates—nature, occurrence and dietary burden. J Sci Food Agric 79:362–372, 1999.
11. Y.Wang, C.T.Ho: Polyphenolic chemistry of tea and coffee: a century of progress. J Agric Food Chem 57:8109–8114, 2009.
12. A.Farah, M.Monteiro, C.M.Donangelo, S.Lafay: Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr 138:2309–2315, 2008.
13. A.Stalmach, W.Mullen, D.Barron, K.Uchida, T.Yokota, C.Cavin, H.Steiling, G.Williamson, A.Crozier: Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption. Drug Metab Dispos 37:1749–1758, 2009.
14. M.Renouf, P.A.Guy, C.Marmet, A.L.Fraering, K.Longet, J.Moulin, M.Enslen, D.Barron, F.Dionisi, C.Cavin, G.Williamson, H.Steiling: Measurement of caffeic and ferulic acid equivalents in plasma after coffee consumption: small intestine and colon are key sites for coffee metabolism. Mol Nutr Food Res 54:760–766, 2010.
15. M.Monteiro, A.Farah, D.Perrone, L.C.Trugo, C.Donangelo: Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans. J Nutr 137:2196–2201, 2007.
16. J.Zhang, M.Chen, W.Ju, S.Liu, M.Xu, J.Chu, T.Wu: Liquid chromatograph/tandem mass spectrometry assay for the simultaneous determination of chlorogenic acid and cinnamic acid in plasma and its application to a pharmacokinetic study. J Pharm Biomed Anal 51:685–690, 2010.
17. S.Shahrzad, K.Aoyagi, A.Winter, A.Koyama, I.Bitsch: Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr 131:1207–1210, 2001.
18. F.Natella, M.Nardini, F.Belelli, P.Pignatelli, S.Di Santo, A.Ghiselli, F.Violi, C.Scaccini: Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. Br J Nutr 100:1276–1282, 2008.
19. M.J.Tuñón, M.V.García-Mediavilla, S.Sánchez-Campos, J.González-Gallego: Potential of flavonoids as anti-inflammatory agents: modulation of pro-inflammatory gene expression and signal transduction pathways. Curr Drug Metab 10:256–271, 2009.
20. M.Ritter, K.Hohenberger, P.Alter, M.Herzum, J.Tebbe, M.Maisch: Caffeine inhibits cytokine expression in lymphocytes. Cytokine 30:177–181, 2005.
21. M.Richelle, I.Tavazzi, E.Offord: Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving. J Agric Food Chem 49:3438–3442, 2001.
22. A.Svilaas, A.K.Sakhi, L.F.Andersen, T.Svilaas, E.C.Strom, D.R.Jacobs Jr, L.Ose, R.Blomhoff: Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 134:562–567, 2004.
23. C.Huber, J.R.Batchelor, D.Fuchs, A.Hausen, A.Lang, D.Niederwieser, G.Reibnegger, P.Swetly, J.Troppmair, H.Wachter: Immune response–associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J. Exp Med 160:310–316, 1984.
24. C.Murr, B.Widner, B.Wirleitner, D.Fuchs: Neopterin as a marker for immune system activation. Curr Drug Metab 3:175–187, 2002.
25. D.Fuchs, A.A.Moeller, G.Reibnegger, E.Stockle, E.R.Werner, H.Wachter: Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J Acquir Immune Defic Syndr 3:873–876, 1990.
26. E.R.Pfefferkorn: Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 81:908–912, 1984.
27. Y.Ozaki, M.P.Edelstein, D.S.Duch: Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma. Proc Natl Acad Sci USA 85:1242–1246, 1988.
28. D.H.Munn, E.Shafizadeh, J.T.Attwood, I.Bondarev, A.Pashine, A.L.Mellor: Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189:1363–1372, 1999.
29. P.Hwu, M.X.Du, R.Lapointe, M.Do, M.W.Taylor, H.A.Young: Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 164:3596–3599, 2000.
30. K.Schroecksnadel, B.Wirleitner, C.Winkler, D.Fuchs: Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 364:82–90, 2006.
31. M.Jenny, M.Klieber, D.Zaknun, S.Schroecksnadel, K.Kurz, M.Ledochowski, H.Schennach, D.Fuchs: In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors. Inflamm Res 60:127–135, 2010.
32. B.Widner, E.R.Werner, H.Schennach, H.Wachter, D.Fuchs: Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 43:2424–2426, 1997.
33. B.Ou, M.Hampsch-Woodill, R.L.Prior: Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J Agric Food Chem 49:4619–4626, 2001.
34. T.C.Chou, P.Talalay: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27–55, 1984.
35. S.R.Thomas, A.C.Terentis, H.Cai, O.Takikawa, A.Levina, P.A.Lay, M.Freewan, R.Stocker: Post–translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide. J Biol Chem., 282:23778–23787, 2007.
36. G.Werner-Felmayer, E.R.Werner, D.Fuchs, A.Hausen, G.Reibnegger, H.Wachter: Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe Seyler 370:1063–1069, 1989.
37. C.Bruce, D.H.Yates, P.S.Thomas: Caffeine decreases exhaled nitric oxide. Thorax 57:361–363, 2002.
38. J.J.Barone, H.R.Roberts: Caffeine consumption. Food Chem Toxicol 34:119–129, 1996.
39. M.A.Spiller: The chemical components of coffee. Prog Clin Biol Res 158:91–147, 1984.
40. J.A.Gómez-Ruiz, D.S.Leake, J.M.Ames: In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem 55:6962–6969, 2007.
41. S.J.Valadão Vicente, E.Y.Ishimoto, R.J.Cruz, C.D.Seabra Pereira, E.A.Torres: Increase of the activity of phase II antioxidant enzymes in rats after a single dose of coffee. J Agric Food Chem 59:10887–10892, 2011.
42. T.Krakauer: The polyphenol chlorogenic acid inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines. Immunopharmacol Immunotoxicol 24:113–119, 2002.
43. R.Feng, Y.Lu, L.L.Bowman, Y.Qian, V.Castranova, M.Ding: Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 280:27888–27895, 2005.
44. S.Schroecksnadel, M.Jenny, K.Kurz, A.Klein, M.Ledochowski, F.Ueberall, D.Fuchs: LPS-induced NF-kappaB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase. Biochem Biophys Res Comm 399:642–646, 2010.
45. J.Y.Kim, K.S.Jung, K.J.Lee, H.K.Na, H.K.Chun, Y.H.Kho, H.G.Jeong: The coffee diterpene kahweol suppress the inducible nitric oxide synthase expression in macrophages. Cancer Lett 213:147–154, 2004.
46. Z.Zhao, H.S.Shin, H.Satsu, M.Totsuka, M.Shimizu: 5-Caffeoylquinic acid and caffeic acid down-regulate the oxidative stress- and TNF-alpha-induced secretion of interleukin-8 from Caco-2 cells. J Agric Food Chem 56:3863–3868, 2008.
47. L.A.Horrigan, J.P.Kelly, T.J.Connor: Immunomodulatory effects of caffeine: friend or foe? Pharmacol Ther 111:877–892, 2006.
48. H.Bessler, H.Salman, M.Bergman, M.Djaldetti: On the factors modulating the effect of statins on malignant cell proliferation. Cancer Invest 25:279–284, 2007.
49. R.Ulcar, R.Schuligoi, A.Heinemann, B.Santner, R.Amann: Inhibition of prostaglandin biosynthesis in human endotoxin-stimulated peripheral blood monocytes: effects of caffeine. Pharmacology 67:67–71, 2003.
50. L.A.Rosenthal, D.D.Taub, M.A.Moors, K.J.Blank: Methylxanthine-induced inhibition of the antigen- and superantigen-specific activation of T and B lymphocytes. Immunopharmacology 24:203–217, 1992.
51. V.Perera, A.S.Gross, H.Xu, A.J.McLachlan: Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics. J Pharm Pharmacol 63:1161–1168, 2011.
52. M.E.Cuvelier, H.Richard, C.Berset: Comparison of the antioxidant activity of some acid phenols—structure activity relationship. Biosci Biotechnol Biochem 56:324–325, 1992.
53. J.H.Chen, C.T.Ho: Antioxidant activities of caffeic acid and its related hydroxycinnamic acid compounds. J Agric. Food Chem 45:2374–2378, 1997.
54. M.K.Moon, Y.J.Lee, J.S.Kim, D.G.Kang, H.S.Lee: Effect of caffeic acid on tumor necrosis factor-alpha-induced vascular inflammation in human umbilical vein endothelial cells. Biol Pharm Bull 32:1371–1377, 2009.
55. F.Ferk, A.Chakraborty, W.Jäger, M.Kundi, J.Bichler, M.Mišík, K.H.Wagner, B.Grasl-Kraupp, S.Sagmeister, G.Haidinger, C.Hoelzl, A.Nersesyan, M.Dušinská, T.Simić, S.Knasmüller: Potent protection of gallic acid against DNA oxidation: results of human and animal experiments. Mutat Res 715:61–71, 2011.
56. F.Fallarino, U.Grohmann, C.Vacca, C.Orabona, A.Spreca, M.C.Fioretti, P.Puccetti: T cell apoptosis by kynurenines. Adv Exp Med Biol 527:183–190, 2003.
57. K.Becker, S.Schroecksnadel, J.Gostner, C.Zaknun, H.Schennach, F.Uberall, D.Fuchs: Comparison of in vitro tests for antioxidant and immunomodulatory capacities of compounds. Phytomedicine 21:164–171, 2014.
58. A.Zampelas, D.B.Panagiotakos, C.Pitsavos, C.Chrysohoou, C.Stefanadis: Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr 80:862–867, 2004.
59. L.F.Andersen, D.R.Jacobs Jr, M.H.Carlsen, R.Blomhoff: Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 83:1039–1046, 2006.
60. M.Montagnana, E.J.Favaloro, G.Lippi: Coffee intake and cardiovascular disease: virtue does not take center stage. Semin Thromb Hemost 38:164–177, 2012.
61. B.Widner, A.Laich, B.Sperner-Unterweger, M.Ledochowski, D.Fuchs: Neopterin production tryptophan degradation and mental depression: what is the link? Brain Behav Immun 16:590–595, 2002.
62. L.Capuron, R.Dantzer: Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17:119–124, 2003.
63. B.Widner, F.Leblhuber, J.Walli, G.P.Tilz, U.Demel, D.Fuchs: Tryptophan degradation and immune activation in Alzheimer's disease. J Neural Transm 107:343–353, 2000.
64. B.Widner, F.Leblhuber, D.Fuchs: Increased neopterin production and tryptophan degradation in advanced Parkinson's disease. J Neural Transm 109:181–189, 2002.
65. J.L.Barranco Quintana, M.F.Allam, A.Serrano Del Castillo, R.Fernández-Crehuet Navajas: Alzheimer's disease and coffee: a quantitative review. Neurol Res 29:91–95, 2007.
66. G.Hu, S.Bidel, P.Jousilahti, R.Antikainen, J.Tuomilehto: Coffee and tea consumption and the risk of Parkinson's disease. Mov Disord 22:2242–2248, 2007.
67. I.Kawachi, W.C.Willett, G.A.Colditz, M.J.Stampfer, F.E.Speizer: A prospective study of coffee drinking and suicide in women. Arch Intern Med 156:521–525, 1996.
68. A.Tanskanen, J.Tuomilehto, H.Viinamaki, E.Vartiainen, J.Lehtonen, P.Puska: Heavy coffee drinking and the risk of suicide. Eur J Epidemiol 16:789–791, 2000.
69. M.D.Gershon, J.Tack: The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132:397–414, 2007.